-
1 Comment
Renhe Pharmacy Co., Ltd is currently in a long term uptrend where the price is trading 27.2% above its 200 day moving average.
From a valuation standpoint, the stock is 77.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Renhe Pharmacy Co., Ltd's total revenue sank by 8.4% to $1B since the same quarter in the previous year.
Its net income has increased by 10.5% to $128M since the same quarter in the previous year.
Finally, its free cash flow grew by 164.1% to $55M since the same quarter in the previous year.
Based on the above factors, Renhe Pharmacy Co., Ltd gets an overall score of 4/5.
| Industry | Drug Manufacturers-Specialty & Generic |
|---|---|
| ISIN | CNE000000NF8 |
| Sector | Healthcare |
| CurrencyCode | CNY |
| Exchange | SHE |
| PE Ratio | 15.02 |
|---|---|
| Target Price | 13.3 |
| Beta | 0.35 |
| Market Cap | 9B |
| Dividend Yield | 1.5% |
Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, topical lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000650.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
